My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 237

    1.

    Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure.

    Somm E, Henrichot E, Pernin A, Juge-Aubry CE, Muzzin P, Dayer JM, Nicklin MJ, Meier CA.

    Diabetes. 2005 Dec;54(12):3503-9.PMID: 16306368 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice.

    Chida D, Osaka T, Hashimoto O, Iwakura Y.

    Diabetes. 2006 Apr;55(4):971-7.PMID: 16567518 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents.

    Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, Juge-Aubry CE, Dayer JM, Nicklin MJ, Meda P, Rohner-Jeanrenaud F, Meier CA.

    Diabetologia. 2006 Feb;49(2):387-93. Epub 2005 Dec 30.PMID: 16385385 [PubMed - indexed for MEDLINE]Related articles

    4.

    IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions.

    Matsuki T, Horai R, Sudo K, Iwakura Y.

    J Exp Med. 2003 Sep 15;198(6):877-88.PMID: 12975454 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Double leptin and melanocortin-4 receptor gene mutations have an additive effect on fat mass and are associated with reduced effects of leptin on weight loss and food intake.

    Trevaskis JL, Butler AA.

    Endocrinology. 2005 Oct;146(10):4257-65. Epub 2005 Jun 30. Erratum in: Endocrinology. 2005 Dec;146(12):5387. PMID: 15994342 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation.

    Juge-Aubry CE, Somm E, Giusti V, Pernin A, Chicheportiche R, Verdumo C, Rohner-Jeanrenaud F, Burger D, Dayer JM, Meier CA.

    Diabetes. 2003 May;52(5):1104-10.PMID: 12716739 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Interleukin-1 receptor antagonist gene polymorphism and traditional classification in obese women.

    Um JY, Kim HM, Mun SW, Song YS, Hong SH.

    Int J Neurosci. 2006 Jan;116(1):39-53.PMID: 16318998 [PubMed - indexed for MEDLINE]Related articles

    8.

    IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

    Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM.

    J Clin Endocrinol Metab. 2002 Mar;87(3):1184-8.PMID: 11889184 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra).

    Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ.

    Brain Res. 1997 Nov 21;776(1-2):96-104.PMID: 9439800 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regulatory effects of interleukin (IL)-1, interferon-beta, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue.

    Juge-Aubry CE, Somm E, Chicheportiche R, Burger D, Pernin A, Cuénod-Pittet B, Quinodoz P, Giusti V, Dayer JM, Meier CA.

    J Clin Endocrinol Metab. 2004 Jun;89(6):2652-8.PMID: 15181037 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study.

    Ueland T, Kristo C, Godang K, Aukrust P, Bollerslev J.

    J Clin Endocrinol Metab. 2003 Apr;88(4):1492-6.PMID: 12679428 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity.

    Mori MA, Araújo RC, Reis FC, Sgai DG, Fonseca RG, Barros CC, Merino VF, Passadore M, Barbosa AM, Ferrari B, Carayon P, Castro CH, Shimuta SI, Luz J, Bascands JL, Schanstra JP, Even PC, Oliveira SM, Bader M, Pesquero JB.

    Diabetes. 2008 Jun;57(6):1491-500. Epub 2008 Mar 10.PMID: 18332096 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor.

    Irikura VM, Lagraoui M, Hirsh D.

    J Immunol. 2002 Jul 1;169(1):393-8.PMID: 12077269 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist.

    Lundkvist J, Sundgren-Andersson AK, Tingsborg S, Ostlund P, Engfors C, Alheim K, Bartfai T, Iverfeldt K, Schultzberg M.

    Am J Physiol. 1999 Mar;276(3 Pt 2):R644-51.PMID: 10070123 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    On the site and mechanism of action of the anti-obesity effects of interleukin-6.

    Jansson JO, Wallenius K, Wernstedt I, Ohlsson C, Dickson SL, Wallenius V.

    Growth Horm IGF Res. 2003 Aug;13 Suppl A:S28-32. Review.PMID: 12914723 [PubMed - indexed for MEDLINE]Related articles

    16.

    Increased fat:carbohydrate oxidation ratio in Il1ra (-/-) mice on a high-fat diet is associated with increased sympathetic tone.

    Chida D, Hashimoto O, Kuwahara M, Sagara H, Osaka T, Tsubone H, Iwakura Y.

    Diabetologia. 2008 Sep;51(9):1698-706. Epub 2008 Jul 2.PMID: 18594791 [PubMed - indexed for MEDLINE]Related articles

    17.

    The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.

    Jbilo O, Ravinet-Trillou C, Arnone M, Buisson I, Bribes E, Péleraux A, Pénarier G, Soubrié P, Le Fur G, Galiègue S, Casellas P.

    FASEB J. 2005 Sep;19(11):1567-9. Epub 2005 Jul 11.PMID: 16009704 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

    Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y.

    J Exp Med. 2000 Jan 17;191(2):313-20.PMID: 10637275 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.

    Isoda K, Sawada S, Ishigami N, Matsuki T, Miyazaki K, Kusuhara M, Iwakura Y, Ohsuzu F.

    Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1068-73. Epub 2004 Apr 1.PMID: 15059807 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mature-onset obesity in interleukin-1 receptor I knockout mice.

    García MC, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahrén B, Enerback S, Ohlsson C, Wallenius V, Jansson JO.

    Diabetes. 2006 May;55(5):1205-13.PMID: 16644674 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity